Manhattan Scientifics Engages Dian Griesel Int’l.

Developer of Disruptive Technologies in Nanomedicine Initiates Campaign of Corporate Communications to Strengthen Awareness of Company

Manhattan Scientifics, Inc. (OTCQB: MHTX) has engaged Dian Griesel Int’l. (DGI) to manage media relations. DGI will work toward the objective of increasing awareness of the company and its subsidiary Senior Scientific LLC, which has developed and patented technologies that use bio safe nanoparticles and sensitive magnetic sensors to detect and measure cancer cells more rapidly and less expensively than current methods.

“The technology developed by Senior Scientific is highly specific—it measures the exact type of cancer present, and does not generate false positive results from benign growths, calcifications or other spurious signals that complicate current detection methods,” said Manny Tsoupanarias, CEO of Manhattan Scientifics. “It is also very sensitive—it can measure tumors that are 1,000 times smaller than is possible with currently available techniques. We believe this combination of features has the potential to improve how cancer is detected and treated, and represents a significant and much-needed alternative to existing options. As we advance the development of this technology, we believe we have a great opportunity to share our story. We believe DGI’s experience, relationships and creative expertise will enhance our opportunities.”

About Manhattan Scientifics, Inc.

Manhattan Scientifics Inc. (www.mhtx.com) is located in New Mexico, New York and Montreal. It is focused on technology transfer and commercialization of transformative technologies in the nano medicine space. The company is presently developing commercial medical prosthetics applications for its ultra-fine grain metals and plans to commercialize the cancer research work and nano medical applications developed by Senior Scientific LLC, a unit of the Company.

About Dian Griesel Int’l.

With an amazing track record of success, Dian Griesel Int’l. (DGI) is a unique public relations company. DGI creates precise content tailored to client needs that resonates with desired audiences including B2Partners, B2Consumers, B2Media, B2Investors and B2Business. Ever focused on building reputations and brands, DGI-crafted messages are placed via traditional media interviews with print, broadcast and Internet outlets; ghostwritten expert opinion pieces for trades and online publications; original news content creation, placement and social media sharing via our proprietary DGIwire.com; and one-on-one meetings with key peer influencers in the media.

Forward-looking statement

This press release contains forward-looking statements, which are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. Management at Manhattan Scientifics believes that purchase of its shares should be considered to be at the high end of the risk spectrum. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements.

Manhattan Scientifics, Inc. PR & IRMarvin Maslow, 917-923-3300marvin@mhtx.comorCorporate Advisory/PRDian Griesel Int’l.Susan Forman, 212-825-3210sforman@dgicomm.comorFastnet AdvisorsAnthony Furey, 631-665-1234mtfurey@fastnetadvisors.comorHawk AssociatesFrank Hawkins, 305-451-1888f.hawkins@hawkassociates.comorEuropean ContactHerbert Strauss, +43-316-296-316herbert "at" eu-ir.com

Manhattan Scientifics (PK) (USOTC:MHTX)
Historical Stock Chart
From Mar 2024 to Apr 2024